News
Premier, Inc. Reports Fiscal-Year 2023 Third-Quarter Results
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2023 third quarter ended March 31, 2023 and provided
Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common
Agilent to Announce Second-Quarter Fiscal Year 2023 Financial Results May 23
Agilent Technologies Inc. (NYSE: A) will release financial results and hold an earnings conference call for the second quarter of fiscal year 2023 after the stock market closes on Tuesday, May 23
STAAR Surgical to Report First Quarter Results on May 3, 2023
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release financial results for the first quarter
Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that the U.S. FDA has renewed its
Dexcom Reports First Quarter 2023 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2023.
First Quarter 2023 Financial Highlights:
-
Revenue grew 18% versus the same
Dexcom Reports First Quarter 2023 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2023.
First Quarter 2023 Financial Highlights:
-
Revenue grew 18% versus the same
Acadia Healthcare Reports First Quarter 2023 Results
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2023.
First Quarter Highlights
-
Revenue totaled $704.3 million, an
Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes
DexCom, Inc. (Nasdaq: DXCM) (“Dexcom”) announced today that it intends to offer, subject to market conditions and other factors, $1.0 billion aggregate principal amount of Convertible Senior Notes
Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes
DexCom, Inc. (Nasdaq: DXCM) (“Dexcom”) announced today that it intends to offer, subject to market conditions and other factors, $1.0 billion aggregate principal amount of Convertible Senior Notes